FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

38067611000001103: Upadacitinib 15mg modified-release tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Feb 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1159121000001119 Upadacitinib 15mg modified-release tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1159141000001112 Upadacitinib 15mg modified-release tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Upadacitinib 15mg modified-release tablets Is a Upadacitinib true Inferred relationship Existential restriction modifier
Upadacitinib 15mg modified-release tablets Has specific active ingredient Upadacitinib hemihydrate true Inferred relationship Existential restriction modifier
Upadacitinib 15mg modified-release tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tabletmodified-release.oral ontology form and route true Inferred relationship Existential restriction modifier
Upadacitinib 15mg modified-release tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Upadacitinib 15mg modified-release tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Upadacitinib 15mg modified-release tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Upadacitinib 15mg modified-release tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Upadacitinib 15mg modified-release tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Upadacitinib 15mg modified-release tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Upadacitinib 15mg modified-release tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Upadacitinib 15mg modified-release tablets Is a Upadacitinib false Inferred relationship Existential restriction modifier
Upadacitinib 15mg modified-release tablets Has specific active ingredient Upadacitinib hemihydrate false Inferred relationship Existential restriction modifier
Upadacitinib 15mg modified-release tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Upadacitinib false Inferred relationship Existential restriction modifier
Upadacitinib 15mg modified-release tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Upadacitinib false Inferred relationship Existential restriction modifier
Upadacitinib 15mg modified-release tablets Plays role Antirheumatic therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Rinvoq 15mg modified-release tablets (AbbVie Ltd) Is a True Upadacitinib 15mg modified-release tablets Inferred relationship Existential restriction modifier
Upadacitinib 15mg modified-release tablets 28 tablet Has VMP True Upadacitinib 15mg modified-release tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start